- Home
- RGS vs FLNA Comparison
RGS vs FLNA Comparison
Compare RGS & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGS | FLNA |
|---|---|---|
| Founded | 1922 | 1998 |
| Country | United States | United States |
| Employees | N/A | 20 |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 61.8M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGS | FLNA |
|---|---|---|
| Price | $28.00 | $1.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.2K | ★ 395.0K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.24 | N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $210,134,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.85 | ★ N/A |
| Revenue Growth | ★ 3.52 | N/A |
| 52 Week Low | $18.23 | $1.16 |
| 52 Week High | $31.50 | $2.03 |
Technical Indicators
Market Signals| Indicator | RGS | FLNA |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 55.33 |
| Support Level | $25.95 | $1.16 |
| Resistance Level | $28.51 | $1.80 |
| Average True Range (ATR) | 1.03 | 0.09 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 56.88 | 76.95 |
Price Performance
Historical ComparisonAbout RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.